Your Variation Identification Agent for Post Approval Change Management Watch Via in Action
May 2026The UK government has updated its guidance on the export of drugs, medicines, and controlled pharmaceutical products, outlining regulatory requirements for human and veterinary medicinal exports.
The guidance explains how exporters must obtain the necessary permissions from authorities such as the Home Office, Medicines and Healthcare products Regulatory Agency (MHRA), and Veterinary Medicines Directorate (VMD).
Key updates include the consolidation of export certificate templates (6-May-2026), revised fee structures, and updated certification requirements for veterinary medicines.
The document covers exports of controlled drugs, medicines used in lethal injections, pharmaceutical ingredients, and veterinary products, along with required licenses and export certificates.
Exporters are advised to confirm destination-country requirements, maintain compliant documentation, and use approved certificate templates for submissions.
This guidance helps pharmaceutical companies ensure regulatory compliance, smooth international trade, and proper certification for medicinal product exports from the UK.
Region: United Kingdom
Reach out to us and let’s unravel your Regulatory puzzle together. Unlock regulatory solutions with our global subject matter experts and tap into a wealth of regulatory intelligence.
Speak to an Expert
